LNC Therapeutics is a biotech company specializing in gut microbiome-based drug discovery. It is engaged in exploring and optimizing single bacterial strains to deliver microbiome-based therapies for obesity, metabolic disorders, inflammation, and neurology.
|Employees (est.) (Oct 2020)||23||(-4%)|
LNC Therapeutics total Funding
LNC Therapeutics latest funding size
Time since last funding
|3 years ago|
LNC Therapeutics investors
|Seventure Partners, Aqui-Invest, GSO Capital Partners|
LNC Therapeutics has 1.78k Twitter Followers. The number of followers has increased 0.2% month over month and decreased 0.1% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was LNC Therapeutics founded?
LNC Therapeutics was founded in 2010.
Who are LNC Therapeutics key executives?
LNC Therapeutics's key executives are Georges Rawadi, Sandrine Claus and Fabrice Guez.
How many employees does LNC Therapeutics have?
LNC Therapeutics has 23 employees.
Who are LNC Therapeutics competitors?
Competitors of LNC Therapeutics include BIOHM, Brii Biosciences and Prevail Therapeutics.
Where is LNC Therapeutics headquarters?
LNC Therapeutics headquarters is located at 17 Place de la Bourse, Bordeaux.
Where are LNC Therapeutics offices?
LNC Therapeutics has an office in Bordeaux.
How many offices does LNC Therapeutics have?
LNC Therapeutics has 2 offices.
Receive alerts for 300+ data fields across thousands of companies